@ECDC_EU data on the incidence of cases, attributable deaths and disability adjusted life years due to MDR bacterial infections in the EU in 2015 https://t.co/sPStfnaTih
Here we show (in rats) that #antibiotic exposure during pregnancy affects the development of the intestinal #microbiome in offspring and causes changes in body weight persisting into adulthood https://t.co/WhE9fJEQDK #earlylife@foodDTUdk@NEXSKU
AMR Control 2018 published by Global Health Dynamics in association with the World Alliance Against Antibiotic Resistance (WAAAR) is available here https://t.co/kDLQaj0PgK
Science article about arylomycin derivatives engineered at Genetech that are active against a range of Gram negative pathogens in mice https://t.co/T8qXEQXuCO
Interesting review concludes that maintaining a complex gut microbiota that fills up metabolic niches, resists pathogen colonization and boosts immune defenses has now become a crucial part of our efforts to fight against infectious diseases. https://t.co/UJ7uxNweED
FDA Unveils Plan to Combat Antibiotic Resistance by supporting antibiotic innovation and ensure that antimicrobial drugs are used according to good stewardship practices at a live event tomorrow https://t.co/L5J0lvjYKP
Very interesting Open Access review of factors contributing to global AMR concludes that reduction of antibiotic consumption will not be sufficient to control AMR https://t.co/E7UC1UGbv5
Interesting article on the adaptation of a commercially available phage mixture used for treating UTIs that increased the sensitivity of 118 uropathogenic strains from 41% to 75% https://t.co/kNScunsWfc
Paratek obtains FDA approval for its antibiotic Omadacycline for treating both acute bacterial skin infections and community-acquired bacterial pneumonia.
https://t.co/GRGXCDdnmy
The Director of the Dr Foster Research Unit at Imperial College reports that UK Hospital sepsis deaths have increased by a third in 2 years https://t.co/TIsgLzSWEf
The carbapenem, Tebipenem, offers an oral option, particularly as step-down therapy in the treatment of serious Gram-negative infections. https://t.co/3PK6yYY4zc